The current study strongly suggested that the low and recessive population-specific genetic variant rs3734091 of XRCC4 may influence the risk of non-BRCA1/2 breast cancer, which could be missed by routine GWAS analyses of women of European ancestry. This evidence concerns the gene BRCA1 and breast carcinoma.